圍手術期護理（兒科）
止血的管理和優化
抗纖溶藥物
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. （開啟新視窗）
來源: Pediatr Surg Int 2012;28(11):1059-69.
檢索: PubMed 22940882
DOI碼: 10.1007/s00383-012-3167-6
Use of tranexamic acid as a rescue measure to achieve hemostasis after massive blood loss in a pediatric neurosurgical patient. （開啟新視窗）
來源: J Neurosurg Anesthesiol 2011;23(4):376-7.
檢索: PubMed 21876453
DOI碼: 10.1097/ANA.0b013e31822c804f
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. （開啟新視窗）
來源: Br J Anaesth 2012;108(5):830-7.
檢索: PubMed 22362670
DOI碼: 10.1093/bja/aes002
A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] （開啟新視窗）
來源: Can J Anaesth 2008;55(1):47-51.
檢索: PubMed 18166748
DOI碼: 10.1007/BF03017597
Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. （開啟新視窗）
來源: Spine (Phila Pa 1976) 2008;33(24):2577-80.
檢索: PubMed 19011538
DOI碼: 10.1097/BRS.0b013e318188b9c5
The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. （開啟新視窗）
來源: Anesth Analg 2014;118(3):628-36.
檢索: PubMed 24557107
DOI碼: 10.1213/ANE.0000000000000080
The effect of Amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. （開啟新視窗）
來源: Spine 2004;29(3):233-8.
檢索: PubMed 14752343
A randomized control trial to verify the efficacy of pre-operative intravenous tranexamic acid in the control of tonsillectomy bleeding. （開啟新視窗）
來源: Indian J Otolaryngol Head Neck Surg 2011;63(1):20-6.
檢索: PubMed 22319712
DOI碼: 10.1007/s12070-010-0095-4
Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. （開啟新視窗）
來源: Anesthesiology 2011;114(4):862-71.
檢索: PubMed 21364458
DOI碼: 10.1097/ALN.0b013e318210fd8f
Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent scoliosis surgery: a randomized placebo-controlled trial. （開啟新視窗）
來源: J Bone Joint Surg Am 2018;100(23):2024-32.
檢索: PubMed 30516625
DOI碼: 10.2106/JBJS.18.00314
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
檢索: PubMed 22075061
DOI碼: 10.1016/j.jtcvs.2011.08.051
Anesthetic management for transfusion-free Rastelli's procedure in a pediatric Jehovah's Witness patient. （開啟新視窗）
來源: Korean J Anesthesiol 2013;65(6 Suppl):S87-8.
檢索: PubMed 24478887
DOI碼: 10.4097/kjae.2013.65.6S.S87
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. （開啟新視窗）
來源: PLoS One 2015;10(5):e0126514.
檢索: PubMed 25954976
DOI碼: 10.1371/journal.pone.0126514
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. （開啟新視窗）
來源: Eur J Cardiothorac Surg 2011;39(6):892-7.
檢索: PubMed 21115357
DOI碼: 10.1016/j.ejcts.2010.09.041
Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures. （開啟新視窗）
來源: Spine (Phila Pa 1976) 2012;37(23):E1459-63.
檢索: PubMed 22872217
DOI碼: 10.1097/BRS.0b013e31826c9fe4
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2012;143(3):550-7.
檢索: PubMed 22264414
DOI碼: 10.1016/j.jtcvs.2011.06.048
Use of tranexamic acid in infants undergoing choroid plexus papilloma surgery: a report of two cases. （開啟新視窗）
來源: Paediatr Anaesth 2014;24(7):791-3.
檢索: PubMed 24924340
DOI碼: 10.1111/pan.12447
The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. （開啟新視窗）
來源: Pediatr Crit Care Med 2009;10(2):182-90.
檢索: PubMed 19188875
DOI碼: 10.1097/PCC.0b013e3181956d61
The role of Amicar in same-day anterior and posterior spinal fusion for idiopathic scoliosis. （開啟新視窗）
來源: Spine (Phila Pa 1976) 2008;33(20):2237-42.
檢索: PubMed 18794767
DOI碼: 10.1097/BRS.0b013e31817bd889
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. （開啟新視窗）
來源: Ann Card Anaesth 2010;13(2):110-5.
檢索: PubMed 20442540
DOI碼: 10.4103/0971-9784.62935
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. （開啟新視窗）
來源: Anesthesiology 2015;122(4):746-58.
檢索: PubMed 25585004
DOI碼: 10.1097/ALN.0000000000000570
Does the intraoperative tranexamic acid decrease operative blood loss during posterior spinal fusion for treatment of adolescent idiopathic scoliosis? （開啟新視窗）
來源: Spine (Phila Pa 1976) 2012;37(21):E1336-42.
檢索: PubMed 22772572
DOI碼: 10.1097/BRS.0b013e318266b6e5
重組活化凝血因子VII（rFVIIa）
Pediatric off-label use of recombinant factor VIIa. （開啟新視窗）
來源: Pediatrics 2009;123(3):1066-72.
檢索: PubMed 19255041
DOI碼: 10.1542/peds.2008-1685
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. （開啟新視窗）
來源: Indian J Pediatr 2011;78(8):961-8.
檢索: PubMed 21328080
DOI碼: 10.1007/s12098-011-0364-6
Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. （開啟新視窗）
來源: Paediatr Anaesth 2006;16(10):1042-6.
檢索: PubMed 16972833
DOI碼: 10.1111/j.1460-9592.2006.02039.x
A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery. [Chirurgie de la scoliose chez un enfant Témoin de Jéhovah souffrant d’hémophilie B et présentant des inhibiteurs du facteur IX.] [English, French abstract] （開啟新視窗）
來源: Can J Anaesth 2008;55(1):47-51.
檢索: PubMed 18166748
DOI碼: 10.1007/BF03017597
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. （開啟新視窗）
來源: Anesth Analg 2012;115(2):364-78.
檢索: PubMed 22652310
DOI碼: 10.1213/ANE.0b013e31825aff10
The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review. （開啟新視窗）
來源: Thromb Haemost 2004;92(4):738-46.
檢索: PubMed 15467904
DOI碼: 10.1160/TH04-03-0163
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
檢索: PubMed 21835642
DOI碼: 10.1053/j.jvca.2011.05.012
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. （開啟新視窗）
來源: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
檢索: PubMed 22371937
DOI碼: 10.1177/0218492311432584
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. （開啟新視窗）
來源: Pediatr Hematol Oncol 2008;25(4):301-11.
檢索: PubMed 18484474
DOI碼: 10.1080/08880010802016904
Off-label use of rFVIIa in children with excessive bleeding: a consecutive study of 153 off-label uses in 139 children. （開啟新視窗）
來源: Pediatr Blood Cancer 2009;53(2):179-83.
檢索: PubMed 19415741
DOI碼: 10.1002/pbc.22053
凝血因子濃縮劑
Emergent pediatric anticoagulation reversal using a 4-factor prothrombin complex concentrate. （開啟新視窗）
來源: Am J Emerg Med 2016;34(6):1182.e1-2.
檢索: PubMed 26652577
DOI碼: 10.1016/j.ajem.2015.10.041
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. （開啟新視窗）
來源: Artif Organs 2010;34(11):955-60.
檢索: PubMed 21092037
DOI碼: 10.1111/j.1525-1594.2010.01148.x
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. （開啟新視窗）
來源: Eur J Anaesthesiol 2014;31(6):317-26.
檢索: PubMed 24503704
DOI碼: 10.1097/EJA.0000000000000043
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
檢索: PubMed 24951020
DOI碼: 10.1016/j.jtcvs.2014.04.029
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. （開啟新視窗）
來源: Vox Sang 2016;110(3):253-7.
檢索: PubMed 26509839
DOI碼: 10.1111/vox.12353
去氨加壓素
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. （開啟新視窗）
來源: AANA J 2007;75(4):261-4.
檢索: PubMed 17711156
利用血液粘彈性檢測辨別外科性出血或凝血病出血
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. （開啟新視窗）
來源: Ann Card Anaesth 2012;15(1):26-31.
檢索: PubMed 22234018
DOI碼: 10.4103/0971-9784.91477
Perioperative bleeding management in pediatric patients. （開啟新視窗）
來源: Curr Opin Anaesthesiol 2016;29(3):352-8.
檢索: PubMed 26844864
DOI碼: 10.1097/ACO.0000000000000308
Management of dilutional coagulopathy during pediatric major surgery. （開啟新視窗）
來源: Transfus Med Hemother 2012;39(2):114-9.
檢索: PubMed 22670129
DOI碼: 10.1159/000337245
Higher fibrinogen concentrations for reduction of transfusion requirements during major paediatric surgery: a prospective randomised controlled trial. （開啟新視窗）
來源: Br J Anaesth 2015;115(2):234-43.
檢索: PubMed 25982134
DOI碼: 10.1093/bja/aev136
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. （開啟新視窗）
來源: Br J Anaesth 2015;114(1):91-102.
檢索: PubMed 25303988
DOI碼: 10.1093/bja/aeu339
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. （開啟新視窗）
來源: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
檢索: PubMed 21924639
DOI碼: 10.1053/j.jvca.2011.07.012
Activated coagulation time vs. intrinsically activated modified rotational thromboelastometry in assessment of hemostatic disturbances and blood loss after protamine administration in elective cardiac surgery: analysis from the clinical trial (NCT01281397). （開啟新視窗）
來源: J Cardiothorac Surg 2014;9:129.
檢索: PubMed 25231271
DOI碼: 10.1186/1749-8090-9-129